Biotech Specialty Pharma

PDS Biotechnology Corporation

675 US Highway one
North Brunswick, NJ 08902 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Potent nanoparticle therapy to treat head and neck cancers

Management Frank Bedu-Addo, PhD, President and CEO Gregory Conn,PhD, CSO

Click here for Financial Data
Keywords: Oncology, Infectious Disease


Updated: Dec. 17, 2014


PDS Biotechnology Corporation (PDS) was founded to commercialize a new generation of safer and more potent therapeutic/curative vaccines to treat various cancers and infectious diseases. PDS owns Ver......view more

Products / Services

Safe and effective treatments for cancer and infectious diseases. PDS0101 - Cervical cancer therapy, head and neck cancer therapy. Subcutaneous injection. High efficacy in treating the cancer, ......view more

Technology / Differentiation

The proprietary VersamuneTM based products are the first pharmaceuticals to be based on a pure active cationic lipid enantiomer. The technology overcomes the following major drawbacks associated ...view more

Market / Customers

PDS0101 - Indications: Human Papillomavirus (HPV) related infection & cancers, e.g. cervical cancer & head and neck cancer. HPV is the most prevalent sexually transmitted agent worldwide. Over 400......view more

Competitors / Substitutes / Alternatives

Advances in curative vaccine research suggest that this class of therapies provide great potential to successfully treat cancer and various infectious diseases. As a result of an improved underst...view more


PDS is collaborating with experts in the field of cancer vaccines at the NIH/ National Cancer Institute to maximize potential for clinical success of the company's products. PDS expects to generate...view more

Revenue / Funding

PDS is raising a Series A round of capital to support phase I human clinical trials for the company's lead product. The funds will cover clinical manufacturing and operational costs. A CRADA has...view more


PDS Biotechnology is a privately funded company. The company's lead patent was issued in December 2007 and additional patents have been submitted. The company has close collaborations with the N...view more


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in /home/onemedpl/public_html/include/counter.php:10 Stack trace: #0 /home/onemedpl/public_html/database/comp_profile_include.php(1079): include() #1 /home/onemedpl/public_html/database/comp_profile.php(87): include('/home/onemedpl/...') #2 {main} thrown in /home/onemedpl/public_html/include/counter.php on line 10